Patent 7507768 was granted and assigned to Bristol-Myers Squibb on March, 2009 by the United States Patent and Trademark Office.
An antidiabetic pharmaceutical formulation is provided, especially adapted for treating Type II diabetes, which includes a combination of metformin and glipizide in a manner to control moisture in the formulation so that the glipizide does not hydrolyze, yet the metformin is compressible, if necessary. A method for treating diabetes is also provided employing the above formulation.